S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
Modern Day Options Trading For Beginners! (Ad)pixel
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
Modern Day Options Trading For Beginners! (Ad)pixel
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
Modern Day Options Trading For Beginners! (Ad)pixel
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
These Indicators Are Pointing To a Rally In Bank Of America, Soon
S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
Modern Day Options Trading For Beginners! (Ad)pixel
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
Modern Day Options Trading For Beginners! (Ad)pixel
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
Modern Day Options Trading For Beginners! (Ad)pixel
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
These Indicators Are Pointing To a Rally In Bank Of America, Soon
S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
Modern Day Options Trading For Beginners! (Ad)pixel
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
Modern Day Options Trading For Beginners! (Ad)pixel
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
Modern Day Options Trading For Beginners! (Ad)pixel
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
These Indicators Are Pointing To a Rally In Bank Of America, Soon
S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
Modern Day Options Trading For Beginners! (Ad)pixel
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
Modern Day Options Trading For Beginners! (Ad)pixel
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
Modern Day Options Trading For Beginners! (Ad)pixel
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
These Indicators Are Pointing To a Rally In Bank Of America, Soon
NASDAQ:CDNA

CareDx - CDNA Stock Forecast, Price & News

$9.08
+0.13 (+1.45%)
(As of 03/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$8.92
$9.29
50-Day Range
$8.83
$17.61
52-Week Range
$8.10
$40.42
Volume
594,513 shs
Average Volume
1.48 million shs
Market Capitalization
$487.32 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$16.00

CareDx MarketRank™ Forecast

Analyst Rating
Hold
2.40 Rating Score
Upside/​Downside
76.2% Upside
$16.00 Price Target
Short Interest
Bearish
9.87% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.66
Upright™ Environmental Score
News Sentiment
0.42mentions of CareDx in the last 14 days
Based on 4 Articles This Week
Insider Trading
Selling Shares
$492,669 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($1.12) to ($0.75) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.22 out of 5 stars

Medical Sector

285th out of 995 stocks

Medical Laboratories Industry

11th out of 26 stocks


CDNA stock logo

About CareDx (NASDAQ:CDNA) Stock

CareDx, Inc. operates as a transplant diagnostics company, which discovers, develops and commercializes diagnostic solutions. Its products include AlloMap, AlloSure and Laboratory products. The company was founded on December 21, 1998 and is headquartered in Brisbane, CA.

Receive CDNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CareDx and its competitors with MarketBeat's FREE daily newsletter.

CDNA Stock News Headlines

Fed's Shocking New Plan to Control Your Money
The Federal Reserve has a disturbing plan that is getting ready to roll out as soon as May. This is a lot more than printing trillions of dollars or manipulating interest rates. It's about every checking account, every purchase and every money transfer in America — including yours and mine. 
Fed's Shocking New Plan to Control Your Money
The Federal Reserve has a disturbing plan that is getting ready to roll out as soon as May. This is a lot more than printing trillions of dollars or manipulating interest rates. It's about every checking account, every purchase and every money transfer in America — including yours and mine. 
CareDx Reports Fourth Quarter and Full Year 2022 Results
CareDx Announces $50 Million Stock Repurchase Program
See More Headlines
Receive CDNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CareDx and its competitors with MarketBeat's FREE daily newsletter.

CDNA Company Calendar

Last Earnings
10/28/2021
Today
3/27/2023
Next Earnings (Estimated)
5/04/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Medical laboratories
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:CDNA
Employees
633
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$16.00
High Stock Price Forecast
$25.00
Low Stock Price Forecast
$9.00
Forecasted Upside/Downside
+76.2%
Consensus Rating
Hold
Rating Score (0-4)
2.40
Research Coverage
5 Analysts

Profitability

Net Income
$-76,610,000.00
Pretax Margin
-23.69%

Debt

Sales & Book Value

Annual Sales
$321.79 million
Book Value
$8.05 per share

Miscellaneous

Free Float
51,205,000
Market Cap
$487.32 million
Optionable
Optionable
Beta
1.03

Key Executives

  • Reginald SeetoReginald Seeto
    President, Chief Executive Officer & Director
  • Abhishek Jain
    Chief Financial & Accounting Officer
  • Amitabh Shukla
    Senior Vice President-Technology
  • Sham Dholakia
    Senior VP-Medical Affairs & Clinical Operations
  • Robert N. Woodward
    Vice President-Research & Development













CDNA Stock - Frequently Asked Questions

Should I buy or sell CareDx stock right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CareDx in the last twelve months. There are currently 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" CDNA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CDNA, but not buy additional shares or sell existing shares.
View CDNA analyst ratings
or view top-rated stocks.

What is CareDx's stock price forecast for 2023?

5 equities research analysts have issued 12-month target prices for CareDx's shares. Their CDNA share price forecasts range from $9.00 to $25.00. On average, they anticipate the company's share price to reach $16.00 in the next year. This suggests a possible upside of 76.2% from the stock's current price.
View analysts price targets for CDNA
or view top-rated stocks among Wall Street analysts.

How have CDNA shares performed in 2023?

CareDx's stock was trading at $11.41 at the start of the year. Since then, CDNA stock has decreased by 20.4% and is now trading at $9.08.
View the best growth stocks for 2023 here
.

When is CareDx's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 4th 2023.
View our CDNA earnings forecast
.

How were CareDx's earnings last quarter?

CareDx, Inc (NASDAQ:CDNA) released its earnings results on Thursday, October, 28th. The company reported $0.07 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.14) by $0.21. The company earned $75.60 million during the quarter, compared to analysts' expectations of $74.11 million. CareDx had a negative trailing twelve-month return on equity of 17.33% and a negative net margin of 23.81%. CareDx's revenue for the quarter was up 41.6% on a year-over-year basis. During the same quarter last year, the company earned ($0.06) EPS.

What guidance has CareDx issued on next quarter's earnings?

CareDx issued an update on its FY 2023 earnings guidance on Monday, February, 27th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $328.00 million-$338.00 million, compared to the consensus revenue estimate of $338.42 million.

What other stocks do shareholders of CareDx own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CareDx investors own include Block (SQ), Roku (ROKU), Exact Sciences (EXAS), NVIDIA (NVDA), Advanced Micro Devices (AMD), Tesla (TSLA), Enphase Energy (ENPH), Johnson & Johnson (JNJ), Activision Blizzard (ATVI) and Alibaba Group (BABA).

What is CareDx's stock symbol?

CareDx trades on the NASDAQ under the ticker symbol "CDNA."

Who are CareDx's major shareholders?

CareDx's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include ARK Investment Management LLC (11.56%), ArrowMark Colorado Holdings LLC (7.48%), Sumitomo Mitsui Trust Holdings Inc. (4.79%), Nikko Asset Management Americas Inc. (4.79%), Bamco Inc. NY (3.84%) and Gagnon Securities LLC (2.79%). Insiders that own company stock include Ankur Dhingra, George Bickerstaff, Grace Colon, Michael Brian Bell, Michael Goldberg, Paul Adler, Peter Maag, Ralph Snyderman, Reginald Seeto, Sasha King, Thomas A Thomas and William A Hagstrom.
View institutional ownership trends
.

How do I buy shares of CareDx?

Shares of CDNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is CareDx's stock price today?

One share of CDNA stock can currently be purchased for approximately $9.08.

How much money does CareDx make?

CareDx (NASDAQ:CDNA) has a market capitalization of $487.32 million and generates $321.79 million in revenue each year. The company earns $-76,610,000.00 in net income (profit) each year or ($1.44) on an earnings per share basis.

How many employees does CareDx have?

The company employs 633 workers across the globe.

How can I contact CareDx?

CareDx's mailing address is 1 TOWER PLACE 9TH FLOOR, SOUTH SAN FRANCISCO CA, 94080. The official website for the company is www.caredxinc.com. The company can be reached via phone at (415) 287-2300, via email at caroline.corner@westwicke.com, or via fax at 415-287-2450.

This page (NASDAQ:CDNA) was last updated on 3/28/2023 by MarketBeat.com Staff